TGFB1 and melanoma: Yin et al. demonstrated that the inhibition of TGF-β signalling with TGF-β receptor-I/ALK5 inhibitor or TGF-β–neutralizing antibodies disallows the activation of fibroblasts and inhibits their ability to promote melanoma growth and invasion [124].